Krystal Biotech (KRYS) Competitors $168.91 +3.91 (+2.37%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KRYS vs. TEVA, ITCI, SMMT, GMAB, RDY, MRNA, VTRS, QGEN, ASND, and ROIVShould you be buying Krystal Biotech stock or one of its competitors? The main competitors of Krystal Biotech include Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Viatris (VTRS), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Krystal Biotech vs. Teva Pharmaceutical Industries Intra-Cellular Therapies Summit Therapeutics Genmab A/S Dr. Reddy's Laboratories Moderna Viatris Qiagen Ascendis Pharma A/S Roivant Sciences Teva Pharmaceutical Industries (NYSE:TEVA) and Krystal Biotech (NASDAQ:KRYS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, community ranking, analyst recommendations and earnings. Which has better earnings & valuation, TEVA or KRYS? Krystal Biotech has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B0.93-$1.64B-$1.45-9.37Krystal Biotech$290.52M16.80$10.93M$2.9956.49 Do institutionals and insiders believe in TEVA or KRYS? 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 86.3% of Krystal Biotech shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Comparatively, 14.1% of Krystal Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer TEVA or KRYS? In the previous week, Teva Pharmaceutical Industries had 8 more articles in the media than Krystal Biotech. MarketBeat recorded 24 mentions for Teva Pharmaceutical Industries and 16 mentions for Krystal Biotech. Teva Pharmaceutical Industries' average media sentiment score of 1.10 beat Krystal Biotech's score of 0.87 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 16 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Krystal Biotech 8 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer TEVA or KRYS? Teva Pharmaceutical Industries presently has a consensus target price of $23.43, suggesting a potential upside of 72.52%. Krystal Biotech has a consensus target price of $220.00, suggesting a potential upside of 30.25%. Given Teva Pharmaceutical Industries' higher probable upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Krystal Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Krystal Biotech 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk & volatility, TEVA or KRYS? Teva Pharmaceutical Industries has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Krystal Biotech has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Does the MarketBeat Community favor TEVA or KRYS? Teva Pharmaceutical Industries received 1039 more outperform votes than Krystal Biotech when rated by MarketBeat users. Likewise, 67.85% of users gave Teva Pharmaceutical Industries an outperform vote while only 67.66% of users gave Krystal Biotech an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133467.85% Underperform Votes63232.15% Krystal BiotechOutperform Votes29567.66% Underperform Votes14132.34% Is TEVA or KRYS more profitable? Krystal Biotech has a net margin of 30.69% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Krystal Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% Krystal Biotech 30.69%11.41%10.40% SummaryKrystal Biotech beats Teva Pharmaceutical Industries on 11 of the 18 factors compared between the two stocks. Remove Ads Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRYS vs. The Competition Export to ExcelMetricKrystal BiotechBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.88B$2.90B$5.34B$7.58BDividend YieldN/A1.91%5.11%4.33%P/E Ratio56.4930.3821.6917.79Price / Sales16.80437.98375.7494.27Price / Cash39.38168.6838.1534.64Price / Book5.143.456.443.99Net Income$10.93M-$72.06M$3.20B$247.24M7 Day Performance1.75%4.38%6.47%5.84%1 Month Performance-5.84%-17.34%-6.43%-5.77%1 Year Performance-2.71%-31.04%8.28%-1.97% Krystal Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRYSKrystal Biotech4.7037 of 5 stars$168.91+2.4%$220.00+30.2%-5.0%$4.88B$290.52M56.49210TEVATeva Pharmaceutical Industries2.9882 of 5 stars$13.91+0.8%$23.43+68.5%+0.9%$15.77B$16.54B-9.5936,800Options VolumePositive NewsITCIIntra-Cellular Therapies3.4982 of 5 stars$131.87flat$106.23-19.4%N/A$14.05B$680.50M-151.57560Analyst ForecastPositive NewsSMMTSummit Therapeutics2.6154 of 5 stars$17.32-0.2%$35.40+104.4%+534.1%$12.78B$700,000.00-61.85110Gap UpGMABGenmab A/S4.2241 of 5 stars$18.19-1.1%$41.33+127.2%-35.7%$12.04B$21.53B10.451,660Short Interest ↓Gap DownHigh Trading VolumeRDYDr. Reddy's Laboratories3.0786 of 5 stars$12.59+1.8%$17.00+35.1%-7.5%$10.51B$311.31B20.0424,800Positive NewsHigh Trading VolumeMRNAModerna4.2556 of 5 stars$25.64+2.1%$59.00+130.1%-75.1%$9.91B$3.20B-2.763,900Positive NewsGap UpVTRSViatris2.7984 of 5 stars$7.61-0.1%$10.50+38.0%-33.5%$9.08B$14.74B-10.2837,000High Trading VolumeQGENQiagen3.496 of 5 stars$40.33+5.4%$47.71+18.3%+7.5%$8.96B$1.98B112.296,030High Trading VolumeASNDAscendis Pharma A/S2.2866 of 5 stars$140.14-1.8%$204.64+46.0%+3.4%$8.50B$363.64M-19.741,017News CoveragePositive NewsGap DownROIVRoivant Sciences2.5826 of 5 stars$9.26-2.1%$17.50+89.0%-9.9%$6.61B$122.59M-61.73860Positive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies TEVA Alternatives ITCI Alternatives SMMT Alternatives GMAB Alternatives RDY Alternatives MRNA Alternatives VTRS Alternatives QGEN Alternatives ASND Alternatives ROIV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRYS) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRYS Stock Free KRYS Stock Alerts